Angiotech Pharmaceuticals to participate in JP Morgan Healthcare Conference
05 Januar 2005 - 11:04PM
PR Newswire (US)
Angiotech Pharmaceuticals to participate in JP Morgan Healthcare
Conference VANCOUVER, Jan. 5 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is
scheduled to participate in the 23rd Annual JP Morgan Healthcare
Conference. William Hunter, President and CEO will be making a
25-minute presentation at the conference on Wednesday, January
12th, 2005 at 1:30 pm PST (4:30 pm EST). A live webcast of Dr.
Hunter's remarks will be available to all interested parties at
Angiotech's website at http://www.angiotech.com/ in the Investor
Relations section. To ensure a timely connection to the webcast, it
is recommended that users register at least 15 minutes before the
webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc., a
specialty pharmaceutical company focusing on drug-eluting medical
devices and biomaterials, is dedicated to enhancing the performance
of medical devices and biomaterials through the innovative uses of
pharmacotherapeutics. To find out more about Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), visit our
website at http://www.angiotech.com/. CONTACTS: Todd Young,
Angiotech Pharmaceuticals (Analysts & Investors) (604) 221-7676
ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts)
(604) 221-7676 ext 6996 Eric Starkman, Starkman & Associates
(Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech
Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech
Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext.
6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604)
221-7676 ext. 6996; Eric Starkman, Starkman & Associates
(Media), (212) 252-8545 ext. 12
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals (MM) News-Artikel